Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RaySearch Laboratories AB ( ($SE:RAY.B) ) has shared an update.
RaySearch Laboratories has convened its shareholders to the 2026 Annual General Meeting, which will be held on May 7 at the company’s headquarters in Stockholm. The company is also enabling shareholders to participate via postal voting, reflecting a continued emphasis on flexible corporate governance and broader shareholder access.
To attend in person or by proxy, shareholders must be recorded in the Euroclear Sweden share register by April 28 and give notice by April 30 using the specified channels. Those opting for postal voting must submit a special form or vote electronically by April 30, with clear rules for proxies and nominee-registered shares to ensure proper representation and voting rights.
The most recent analyst rating on ($SE:RAY.B) stock is a Buy with a SEK210.00 price target. To see the full list of analyst forecasts on RaySearch Laboratories AB stock, see the SE:RAY.B Stock Forecast page.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a Swedish medical technology company that develops advanced software solutions for radiation therapy planning and oncology information management. Its products are primarily used by hospitals and cancer centers worldwide to optimize and personalize cancer treatment, strengthening its position in the global radiation oncology software market.
Average Trading Volume: 171,149
Technical Sentiment Signal: Hold
Current Market Cap: SEK6.79B
Learn more about RAY.B stock on TipRanks’ Stock Analysis page.